• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
50,952.25 25.20
(0.05%)
Dow Jones
7,687.74 15.20
(0.20%)
Hang Seng
68,949.71 2,195.99
(3.29%)
Nikkei 225
10,432.22 -173.78
(-1.64%)
Forex
USD-INR
95.92 -0.05
(-0.05%)
EUR-INR
108.79 -0.10
(-0.09%)
GBP-INR
127.19 0.21
(0.17%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
136.4
434279.63
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.88
 

Ritesh International standalone net profit declines 48.02% in the March 2026 quarter
May 21,2026
Net profit of Ritesh International declined 48.02% to Rs 1.05 crore in the quarter ended March 2026 as against Rs 2.02 crore during the previous quarter ended March 2025. Sales rose 29.59% to Rs 48.75 crore in the quarter ended March 2026 as against Rs 37.62 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.52% to Rs 3.68 crore in the year ended March 2026 as against Rs 3.30 crore during the previous year ended March 2025. Sales rose 29.48% to Rs 167.00 crore in the year ended March 2026 as against Rs 128.98 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales48.7537.62 30 167.00128.98 29
OPM %4.318.21 -4.264.39 -
PBDT2.002.91 -31 6.385.06 26
PBT1.772.67 -34 5.544.37 27
NP1.052.02 -48 3.683.30 12